Related Experiment Video
Updated: Nov 5, 2025
07:50
A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
16.1K
BRAF p.V600E associated poly-neoplastic syndrome.
Muhamad Alhaj Moustafa1, Liuyan Jiang2, Justin J Kuhlman3
1Division of Hematology and Medical Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.
Rare Tumors
|May 17, 2021
Summary
A patient developed eight cancers, five linked to the BRAF p.V600E mutation. This unprecedented BRAF p.V600E-associated poly-neoplastic syndrome highlights a novel cancer association.
Area of Science:
- Oncology
- Genetics
- Cancer Biology
Background:
- Multiple primary cancers in a single individual are rare.
- The BRAF p.V600E mutation is a known oncogenic driver in various cancers.
Observation:
- A male patient developed eight distinct cancers between ages 57 and 64.
- BRAF p.V600E mutation was identified in five of the eight cancers: Langerhans cell histiocytosis, chronic lymphocytic leukemia, histiocytic sarcoma, melanoma, and lung adenocarcinoma.
Findings:
- BRAF p.V600E mutation was absent in multiple myeloma, basal cell carcinoma, and papillary thyroid cancer.
- The mutation was not detected in normal skin tissue, confirming its somatic nature.
- This represents the first reported case of a BRAF p.V600E-associated poly-neoplastic syndrome.
Implications:
- This case suggests a potential role for BRAF p.V600E in driving multiple, distinct malignancies.
- Further research into BRAF p.V600E-associated poly-neoplastic syndromes may reveal new therapeutic targets.
- Understanding this phenomenon could advance personalized medicine approaches in oncology.
